Bio-Nucleonics, founded in 1994, is a company specializing in generic radiopharmaceuticals. Their flagship product, the Strontium Chloride Sr89 Injection USP, is a non-opioid pain palliative specifically developed for metastatic bone cancer patients. By providing a high-quality, generic treatment option, Bio-Nucleonics aims to improve the quality of life for those suffering from this condition.